Varyani F[au] - Search Results

Year	Number of Results
2008	2
2011	1
2013	2
2017	1
2018	1
2019	3
2022	2
2023	0

1

Helminths in the gastrointestinal tract as modulators of immunity and pathology.

Varyani F, Fleming JO, Maizels RM. Varyani F, et al. Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G537-G549. doi: 10.1152/ajpgi.00024.2017. Epub 2017 Mar 16. Am J Physiol Gastrointest Liver Physiol. 2017. PMID: 28302598 Free PMC article. Review.

2

Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data.

Varyani F, Argyriou K, Phillips F, Tsakiridou E, Moran GW. Varyani F, et al. Drug Des Devel Ther. 2019 Dec 2;13:4091-4105. doi: 10.2147/DDDT.S182891. eCollection 2019. Drug Des Devel Ther. 2019. PMID: 31819376 Free PMC article. Review.

3

"Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?".

Varyani F, Samuel S. Varyani F, et al. Best Pract Res Clin Gastroenterol. 2019 Feb-Apr;38-39:101621. doi: 10.1016/j.bpg.2019.05.008. Epub 2019 May 31. Best Pract Res Clin Gastroenterol. 2019. PMID: 31327407 Review.

4

The IL-25-dependent tuft cell circuit driven by intestinal helminths requires macrophage migration inhibitory factor (MIF).

Varyani F, Löser S, Filbey KJ, Harcus Y, Drurey C, Poveda MC, Rasid O, White MPJ, Smyth DJ, Gerbe F, Jay P, Maizels RM. Varyani F, et al. Mucosal Immunol. 2022 Jun;15(6):1243-1256. doi: 10.1038/s41385-022-00496-w. Epub 2022 Mar 14. Mucosal Immunol. 2022. PMID: 35288645 Free PMC article.

5

Improving 30-day mortality after PEG tube placement in England from 2007 to 2019: a retrospective national cohort analysis of 87,862 patients.

Kamran U, Lee PC, Coupland B, Abbasi A, Steed H, Ispoglou S, Varyani F, Trudgill N. Kamran U, et al. Among authors: varyani f. Gastrointest Endosc. 2022 Dec;96(6):943-953.e11. doi: 10.1016/j.gie.2022.06.031. Epub 2022 Jul 5. Gastrointest Endosc. 2022. PMID: 35798054

6

Concerted IL-25R and IL-4Rα signaling drive innate type 2 effector immunity for optimal helminth expulsion.

Smith KA, Löser S, Varyani F, Harcus Y, McSorley HJ, McKenzie AN, Maizels RM. Smith KA, et al. Among authors: varyani f. Elife. 2018 Sep 21;7:e38269. doi: 10.7554/eLife.38269. Elife. 2018. PMID: 30238872 Free PMC article.

7

Macrophage Migration Inhibitory Factor (MIF) Is Essential for Type 2 Effector Cell Immunity to an Intestinal Helminth Parasite.

Filbey KJ, Varyani F, Harcus Y, Hewitson JP, Smyth DJ, McSorley HJ, Ivens A, Nylén S, Rottenberg M, Löser S, Maizels RM. Filbey KJ, et al. Among authors: varyani f. Front Immunol. 2019 Oct 24;10:2375. doi: 10.3389/fimmu.2019.02375. eCollection 2019. Front Immunol. 2019. PMID: 31708913 Free PMC article.

8

An increased risk of urinary tract infection precedes development of primary biliary cirrhosis.

Varyani FK, West J, Card TR. Varyani FK, et al. BMC Gastroenterol. 2011 Aug 26;11:95. doi: 10.1186/1471-230X-11-95. BMC Gastroenterol. 2011. PMID: 21871059 Free PMC article.

9

Primary biliary cirrhosis does not increase the risk of UTIs following diagnosis compared to other chronic liver diseases?

Varyani FK, West J, Card TR. Varyani FK, et al. Liver Int. 2013 Mar;33(3):384-8. doi: 10.1111/liv.12107. Liver Int. 2013. PMID: 23402609

10

Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) programme.

MacDonald MR, Petrie MC, Varyani F, Ostergren J, Michelson EL, Young JB, Solomon SD, Granger CB, Swedberg K, Yusuf S, Pfeffer MA, McMurray JJ; CHARM Investigators. MacDonald MR, et al. Among authors: varyani f. Eur Heart J. 2008 Jun;29(11):1377-85. doi: 10.1093/eurheartj/ehn153. Epub 2008 Apr 14. Eur Heart J. 2008. PMID: 18413309 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results